Trials / Completed
CompletedNCT00143221
Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)
A Multicenter, Randomized, Parallel Group, Double-blind, Placebo-controlled Flexible Dose Study With and Open-label Extension to Assess the Efficacy and Safety of Viagra (Sildenafil Citrate) in the Treatment of Men With Erectile Dysfunction (ED) and Concomitant Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) in the United States
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 350 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Viagra is effective in treating erectile dysfunction and lower urinary tract symptoms in men affected by both conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viagra | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-03-01
- Completion
- 2005-05-01
- First posted
- 2005-09-02
- Last updated
- 2021-02-01
Source: ClinicalTrials.gov record NCT00143221. Inclusion in this directory is not an endorsement.